Portal de Periódicos da CAPES

The costs of transfusion: economic evaluations in transfusion medicine, P art 1

2013; Wiley; Volume: 53; Issue: 7 Linguagem: Inglês

10.1111/trf.12188

1537-2995

Seema Kacker, Kevin D. Frick, Aaron A.R. Tobian,

Chronic Kidney Disease and Diabetes

TransfusionVolume 53, Issue 7 p. 1383-1385 CLINICAL RESEARCH FOCUS #34 The costs of transfusion: economic evaluations in transfusion medicine, Part 1 Seema Kacker, Seema Kacker Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MarylandSearch for more papers by this authorKevin D. Frick, Kevin D. Frick Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MarylandSearch for more papers by this authorAaron A.R. Tobian, Corresponding Author Aaron A.R. Tobian Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MarylandAddress reprint requests to: Aaron A.R. Tobian, MD, PhD, Transfusion Medicine Division, Department of Pathology, Johns Hopkins Medical Institutions, 600 N. Wolfe Street, Carnegie 437, Baltimore, MD 21287; e-mail: [email protected].Search for more papers by this author Seema Kacker, Seema Kacker Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MarylandSearch for more papers by this authorKevin D. Frick, Kevin D. Frick Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MarylandSearch for more papers by this authorAaron A.R. Tobian, Corresponding Author Aaron A.R. Tobian Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MarylandAddress reprint requests to: Aaron A.R. Tobian, MD, PhD, Transfusion Medicine Division, Department of Pathology, Johns Hopkins Medical Institutions, 600 N. Wolfe Street, Carnegie 437, Baltimore, MD 21287; e-mail: [email protected].Search for more papers by this author First published: 08 April 2013 https://doi.org/10.1111/trf.12188Citations: 19Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Keehan SP, Cuckler GA, Sisko AM, Madison AJ, Smith SD, Lizonitz JM, Poisal JA, Wolfe CJ. National health expenditure projections: modest annual growth until coverage expands and economic growth accelerates. Health Aff (Millwood) 2012; 31: 1600- 1612. 2 Varney SJ, Guest JF. The annual cost of blood transfusions in the UK. Transfus Med 2003; 13: 205- 218. 3 Amin M, Fergusson D, Aziz A, Wilson K, Coyle D, Hebert P. The cost of allogeneic red blood cells—a systematic review. Transfus Med 2003; 13: 275- 285. 4 Custer B, Hoch JS. Cost-effectiveness analysis: what it really means for transfusion medicine decision making. Transfus Med Rev 2009; 23: 1- 12. 5 Jefferies LC, Sachais BS, Young DS. Blood transfusion costs by diagnosis-related groups in 60 university hospitals in 1995. Transfusion 2001; 41: 522- 529. 6 Kacker S, Frick KD, Tobian A. Establishing a framework: economic evaluations in transfusion medicine, Part 2. Transfusion 2013. doi: 10.1111/trf.12187 7 Kacker S, Frick KD, Tobian A. Constructing a model: economic evaluations in transfusion medicine, Part 3. Transfusion 2013. doi: 10.1111/trf.12186 8 Kacker S, Frick KD, Tobian A. Data and interpretation: economic evaluations in transfusion medicine, Part 4. Transfusion 2013. doi: 10.1111/trf.12185 9 Amin M, Fergusson D, Wilson K, Tinmouth A, Aziz A, Coyle D, Hebert P. The societal unit cost of allogenic red blood cells and red blood cell transfusion in Canada. Transfusion 2004; 44: 1479- 1486. 10 Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753- 765. 11 Shander A, Hofmann A, Gombotz H, Theusinger OM, Spahn DR. Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol 2007; 21: 271- 289. 12 Cremieux PY, Barrett B, Anderson K, Slavin MB. Cost of outpatient blood transfusion in cancer patients. J Clin Oncol 2000; 18: 2755- 2761. 13 Cantor SB, Hudson DV, Jr, Lichtiger B, Rubenstein EB. Costs of blood transfusion: a process-flow analysis. J Clin Oncol 1998; 16: 2364- 2370. 14 Sun D, Abraham I. Cost of allogeneic blood transfusion. World J Hematol 2012; 1: 8- 13. Citing Literature Volume53, Issue7July 2013Pages 1383-1385 ReferencesRelatedInformation